Brad R. Henke
Scientific Advisory Board
medicinal chemistry
ASEDA Sciences
Switzerland
Biography
Dr. Brad Henke is currently president and principal consultant at Opti-Mol Consulting, which provides medicinal chemistry and preclinical drug discovery guidance for pharmaceutical, biotech, academic, and not-for-profit organizations. Previously, Dr. Henke was a senior director of chemistry at GlaxoSmithKline, where he led medicinal chemistry research in the areas of metabolic and skeletal muscle diseases. Dr. Henke has a Ph.D. in organic chemistry from the University of Illinois and over 23 years of experience in discovery and development of both small molecule and peptide-based therapeutics.
Research Interest
Medicinal chemistry and preclinical drug discovery
